Suppr超能文献

阿尔茨海默病 AβPP 转基因小鼠模型行为缺陷的纵向研究。

A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease.

机构信息

JSW LIFESCIENCES, Grambach, Austria.

出版信息

J Alzheimers Dis. 2011;25(2):231-43. doi: 10.3233/JAD-2011-101866.

Abstract

Elucidating the age-dependent alterations in transgenic (Tg) mice overexpressing amyloid-β protein precursor (AβPP) is important for understanding the pathogenesis of Alzheimer's disease (AD) and designing experimental therapies. Cross-studies have previously characterized some time-dependent behavioral and pathological alterations in AβPP Tg mice, however, a more comprehensive longitudinal study is needed to fully examine the progressive nature of behavioral deficits in these mice. In order to better understand the age- and gender-dependent progression of behavioral alterations, we performed a longitudinal study wherein Tg mice overexpressing human AβPP751 with the London (V717I) and Swedish (K670M/N671L) mutations under the regulatory control of the neuron specific murine (m)Thy-1 promoter (mThy1-hAβPP751) were behaviorally analyzed at 3 months and then re-tested at 6 and 9 months of age. The results show that there was an age-associated impairment in learning in the water maze task and habituation in the hole-board task. Motor coordination of the mThy1-hAβPP751 Tg mice was well-preserved throughout the investigated life span however, gender-specific deficits were observed in spontaneous activity and thigmotaxis. Neuropathologically, mThy1-hAβPP751 Tg mice displayed a progressive increase in the number of Aβ plaques and mean plaque size in the cortex and hippocampus from 3 to 6 and from 6 to 9 months of age. Taken together, these results indicate that the mThy1-hAβPP751 Tg mice model AD from the early onset of the disease through to later stages, allowing them to be utilized at numerous points during the timeline for drug test designs.

摘要

阐明过度表达淀粉样前体蛋白(APP)的转基因(Tg)小鼠的年龄依赖性变化对于理解阿尔茨海默病(AD)的发病机制和设计实验性治疗方法非常重要。以前的交叉研究已经描述了 APP Tg 小鼠中一些与时间相关的行为和病理改变,但是需要更全面的纵向研究来充分检查这些小鼠行为缺陷的进行性。为了更好地理解行为改变的年龄和性别依赖性进展,我们进行了一项纵向研究,其中在神经元特异性鼠(m)Thy-1 启动子(mThy1-hAβPP751)的调控下过表达具有伦敦(V717I)和瑞典(K670M/N671L)突变的人 APP751 的 Tg 小鼠在 3 个月时进行行为分析,然后在 6 个月和 9 个月时重新测试。结果表明,在水迷宫任务中的学习和在洞板任务中的习惯化方面存在与年龄相关的损害。mThy1-hAβPP751 Tg 小鼠的运动协调能力在整个研究期间都保持良好,但是在自发活动和触壁性方面观察到性别特异性缺陷。神经病理学上,mThy1-hAβPP751 Tg 小鼠从 3 个月到 6 个月以及从 6 个月到 9 个月,皮质和海马中的 Aβ斑块数量和平均斑块大小呈进行性增加。总之,这些结果表明,mThy1-hAβPP751 Tg 小鼠从疾病的早期开始到后期都表现出 AD 模型,允许在药物测试设计的时间线上的多个点使用它们。

相似文献

10
Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model.
Neurobiol Aging. 2011 Feb;32(2):280-92. doi: 10.1016/j.neurobiolaging.2009.02.021. Epub 2009 Mar 28.

引用本文的文献

5
Characterization of apathy-like behaviors in the 5xFAD mouse model of Alzheimer's disease.
Neurobiol Aging. 2023 Jun;126:113-122. doi: 10.1016/j.neurobiolaging.2023.02.012. Epub 2023 Mar 2.
6
ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer's Disease.
Front Neurosci. 2022 Apr 26;16:848215. doi: 10.3389/fnins.2022.848215. eCollection 2022.
7
The Hole-Board Test in Mutant Mice.
Behav Genet. 2022 May;52(3):158-169. doi: 10.1007/s10519-022-10102-1. Epub 2022 Apr 28.
8
A microRNA signature that correlates with cognition and is a target against cognitive decline.
EMBO Mol Med. 2021 Nov 8;13(11):e13659. doi: 10.15252/emmm.202013659. Epub 2021 Oct 11.
9
Cognitive Reserve in Model Systems for Mechanistic Discovery: The Importance of Longitudinal Studies.
Front Aging Neurosci. 2021 Jan 21;12:607685. doi: 10.3389/fnagi.2020.607685. eCollection 2020.
10
Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer's disease and related murine models.
PLoS One. 2020 Jul 9;15(7):e0235543. doi: 10.1371/journal.pone.0235543. eCollection 2020.

本文引用的文献

1
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.
Neurology. 2010 Jun 15;74(24):2026; author reply 2026-7. doi: 10.1212/WNL.0b013e3181e03844.
2
Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
Brain. 2010 May;133(Pt 5):1312-27. doi: 10.1093/brain/awq056. Epub 2010 Mar 31.
4
Can Alzheimer disease be prevented by amyloid-beta immunotherapy?
Nat Rev Neurol. 2010 Feb;6(2):108-19. doi: 10.1038/nrneurol.2009.219.
5
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.
Neurology. 2009 Dec 15;73(24):2061-70. doi: 10.1212/WNL.0b013e3181c67808. Epub 2009 Nov 18.
6
Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders.
Curr Alzheimer Res. 2009 Apr;6(2):144-51. doi: 10.2174/156720509787602852.
7
Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model.
Neurobiol Aging. 2011 Feb;32(2):280-92. doi: 10.1016/j.neurobiolaging.2009.02.021. Epub 2009 Mar 28.
9
Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
Brain Res. 2008 Jun 24;1216:92-103. doi: 10.1016/j.brainres.2008.03.079. Epub 2008 Apr 10.
10
The exploratory behaviour of rats in the hole-board apparatus: is head-dipping a valid measure of neophilia?
Behav Processes. 2008 Jul;78(3):442-8. doi: 10.1016/j.beproc.2008.02.019. Epub 2008 Mar 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验